Vanguard Personalized Indexing Management
ERNA icon

Vanguard Personalized Indexing Management’s Eterna Therapeutics ERNA Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio ERNA Stock Details ERNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-180
Closed -$12K – 1976
2025
Q1 		$12K Buy
+180
New +$22.2K ﹤0.01% 1818

Other funds holding ERNA

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Corient Private Wealth
Corient Private Wealth Miami, Florida $77.5B AUM 27.94% 1-Year Est. Return
SCA
Sippican Capital Advisors Boston, Massachusetts $164M AUM 35.17% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Vanguard Personalized Indexing Management's ERNA Position: Q2 2025 in Review

Vanguard Personalized Indexing Management sold out of Eterna Therapeutics (ERNA) in Q2 2025, closing a stake of 180 shares — an estimated $12K sold.

Vanguard Personalized Indexing Management first reported a position in ERNA in Q1 2025 and held it in 1 quarter. The position peaked at $12K in Q1 2025. 9 funds tracked by Wall St. Rank hold ERNA as of Q2 2025.

  • Vanguard Personalized Indexing Management reported no remaining Eterna Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Vanguard Personalized Indexing Management sold 180 Eterna Therapeutics shares in Q2 2025, an estimated $12K.
  • Vanguard Personalized Indexing Management first reported a position in Eterna Therapeutics in Q1 2025 and held it in 1 quarter.
  • Vanguard Personalized Indexing Management's Eterna Therapeutics position peaked at $12K in Q1 2025.
  • 9 funds tracked by Wall St. Rank held Eterna Therapeutics as of Q2 2025.

Based on Vanguard Personalized Indexing Management's 13F filing for Q2 2025, filed 25 Jul 2025.